-
ABPI Website
-
Building a stronger reputation in the UK
- Disclosure UK
Disclosure UK
The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines.
It is a relationship that we are proud of. At the core of the relationship is sharing knowledge to improve outcomes for patients. We want to ensure that patients and others have confidence that this relationship is open and transparent and this is why the pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by industry to HCPs and HCOs.
This information will be published on the database - Disclosure UK.
Disclosure UK database
Disclosure UK is part of a Europe-wide initiative to increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals and organisations it works with.
Explore the data further
As well as searching Disclosure UK, you can also review each pharmaceutical company’s methodological note or download the full dataset by year.
2025 timeline for 2024 disclosure data
Submission deadline for companies abiding by the ABPI Code of Practice: 14:00 GMT Friday 28 March 2025
Publication of 2024 data on Disclosure UK: Friday 27 June 2025
See also, the ABPI Code of Practice and supplementary information to clause 31.1 regarding disclosure timelines.
European Disclosure Gateway
To improve access to European data, the pharmaceutical industry has voluntarily created this single point of access to help any interested stakeholder navigate the publicly available data across all EFPIA Members countries whether hosted on individual company websites or centralised on national platforms.
Disclosure UK is an industry-led initiative to deliver a searchable database that shows payments and benefits in kind made by the pharmaceutical industry to doctors, nurses and other health professionals and organisations in the UK.
The resources on this page are available for use by the pharmaceutical industry, healthcare professionals (HCPs) and healthcare organisations (HCOs) to help them understand how Disclosure UK works.
The ABPI is committed to protecting and respecting the privacy of your personal data. This privacy notice explains how your data is collected, used, transferred and disclosed by us.
Disclosure UK publications
-
Guide for healthcare professionals and organisations: How to raise queries about Disclosure UK data - full text
If you are a UK-based healthcare professional (HCP) or healthcare organisation (HCO) and have a received a letter or email notifying you that a pharmaceutical company has disclosed transfers of value about you on Disclosure UK, this short guide shows how to easily review the information and, if necessary, raise queries.
-
Guide for healthcare professionals and organisations: How to raise queries about Disclosure UK data - full text
If you are a UK-based healthcare professional (HCP) or healthcare organisation (HCO) and have a received a letter or email notifying you that a pharmaceutical company has disclosed transfers of value about you on Disclosure UK, this short guide shows how to easily review the information and, if necessary, raise queries.
-
Best practice guidance: Supporting patient organisations to report industry funding
The ABPI has put together some advice for local disclosure mechanisms, based on current practice among industry.
-
Gweithwyr gofal iechyd proffesiynol: Camwch i fyny i Disclosure UK
Heddiw mae cleifion, y cyhoedd, archwilwyr a’r cyfryngau yn disgwyl i’r sector gofal iechyd fod yn agored ynghylch eu cydweithrediadau. Mae Disclosure UK yn eich helpu i fod yn dryloyw ynghylch eich rhyngweithio â chwmnïau fferyllol.
-
Healthcare professionals: Step up to Disclosure UK
Disclosure UK leaflet for healthcare professionals encouraging transparency. Co-branded with other professional healthcare bodies.
-
Disclosure UK gateway FAQs
Information on the Disclosure UK gateways connecting visitors to disclosure information about patient organisations and members of the public.
-
Best practice guidance: Supporting patient organisations to report industry funding
The ABPI Code of Practice places requirements on industry to publish annual lists of payments to patient organisations, and we endorse this approach. Currently, there is no similar requirement for those patient organisations in receipt of grants or funds from industry. In response, the ABPI has put together some advice for local disclosure mechanisms, based on current practice among industry.
-
How we work with HCOs
Factsheet on how and why the pharmaceutical industry works with healthcare organisations
-
How we work with HCPs
Factsheet on how and why the pharmaceutical industry works with healthcare professionals
-
Guide to raising queries about the information on Disclosure UK for HCPs and HCOs
Guide to raising queries about the information on Disclosure UK for HCPs and HCOs.
-
Pre-disclosure factsheet
Information about Disclosure UK for HCPs and HCOs with data disclosed.
-
What is Legitimate Interests?
Data privacy laws in the UK (GDPR) mean that to process personal information about an individual, companies must choose a lawful basis before they do so. There are six bases to choose from, as defined by the Information Commissioner’s Office (ICO). Deciding which basis is most appropriate to use will depend on the purpose and relationship with the individual.